Physician profile
Marc I Dinowitz
NPI 1689613275
$2,248.99
in general payments reported to CMS, 2019-2025
15 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $81.04 · 2021: $613 · 2022: $367 · 2023: $204 · 2024: $314 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $588.30 | 2019-2023 | Xiaflex |
| Skeletal Dynamics INC | $430.18 | 2019-2024 | Align, Implate, Ijs |
| Orthofix Medical, INC. | $316.45 | 2019-2025 | Physio-Stim |
| Impactortho, INC. | $234.02 | 2021-2025 | |
| Ensemble Orthopedics, INC | $100.04 | 2022 | |
| Endo USA, INC. | $94.29 | 2024-2025 | Xiaflex |
| Xtant Medical INC | $92.73 | 2025 | |
| Acumed LLC | $91.81 | 2021 | |
| Medtronic, INC. | $69.78 | 2021-2022 | |
| Axogen | $56.82 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Biocircuit Technologies INC | $49.69 | 2025 | Nerve Tape |
| Abbott Laboratories | $46.85 | 2021-2025 | Proclaim |
| Stryker Corporation | $42.90 | 2023-2025 | Variax |
| Smith+Nephew, INC. | $20.77 | 2024 | Ascension |
| Osteomed LLC | $14.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Dinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.